Arun J. Sanyal

Board Member at SteroTherapeutics

Dr. Arun Sanyal is a Professor of Medicine, Physiology and Molecular Pathology at Virginia Commonwealth University School of Medicine. He has over 25 years of experience as a hepatologist and has served as the secretary and president of the American Association for Study of Liver Diseases, a founding member of the Hepatology board of the American Board of Internal Medicine, Chair of the NIH hepatobiliary pathophysiology study section and Member of the council of the NIH. He has been continuously funded by the NIH for over 25 years.

Dr. Sanyal’s research spans the areas of cirrhosis and alcoholic- and nonalcoholic steatohepatitis (NASH). His work informs several recommendations in national practice guidelines related to the management of variceal hemorrhage, ascites, hepatorenal syndrome, hepatic encephalopathy, and NASH. He has helped establish and chair the “Liver Forum” which brings FDA, European Medical Agency, Academia, NIH and industry stakeholders in NASH and hepatic fibrosis together to accelerate therapeutic development in these areas.

Timeline

  • Board Member

    Current role